BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30421062)

  • 1. ASO Author Reflections: Borrmann Type as a Characteristic Phenotype of Advanced Gastric Cancer.
    Lee HH
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):778-779. PubMed ID: 30421062
    [No Abstract]   [Full Text] [Related]  

  • 2. ASO Author Reflections: Simplified Nomogram Predictive of Survival after R0 Resection for Gastric Cancer.
    Zheng ZF; Lu J; Huang CM
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):733-734. PubMed ID: 30306372
    [No Abstract]   [Full Text] [Related]  

  • 3. ASO Author Reflections: Gastrectomy Within 30 Days After Neoadjuvant Chemotherapy is Associated with the Highest Rate of Major Pathologic Response in Advanced Gastric Cancer.
    Reinsoo A; Bausys A; Ümarik T; Strupas K
    Ann Surg Oncol; 2021 Aug; 28(8):4456-4457. PubMed ID: 33417117
    [No Abstract]   [Full Text] [Related]  

  • 4. ASO Author Reflections: Challenges in Centralization and Standardization of Gastrectomy in the United States to Improve Gastric Cancer Outcomes.
    Ikoma N; Mansfield P
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):770-771. PubMed ID: 31605331
    [No Abstract]   [Full Text] [Related]  

  • 5. ASO Author Reflections: Laparoscopic Hyperthermic Intraperitoneal Chemotherapy for Patients with Metastatic Gastric Cancer.
    Newhook TE; Badgwell BD
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):606-607. PubMed ID: 31069555
    [No Abstract]   [Full Text] [Related]  

  • 6. ASO Author Reflections: The Role of Robotic Gastrectomy for Gastric Cancer.
    Nishi M; Shimada M; Yoshikawa K; Takasu C; Wada Y
    Ann Surg Oncol; 2022 Jun; 29(6):3896-3897. PubMed ID: 34988837
    [No Abstract]   [Full Text] [Related]  

  • 7. Borrmann Type 1 Cancer is Associated with a High Recurrence Rate in Locally Advanced Gastric Cancer.
    Kim JH; Lee HH; Seo HS; Jung YJ; Park CH
    Ann Surg Oncol; 2018 Jul; 25(7):2044-2052. PubMed ID: 29752601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Surgical treatment and prognosis of Borrmann type IIII( gastric cancer involving the whole stomach].
    Dong R; Zhang Z; Zhou Y; Hua Y; Guo J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):185-189. PubMed ID: 29492918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ASO Author Reflections: Prediction of Survival Outcomes Based on Preoperative Clinical Parameters in Gastric Cancer.
    Shin HJ; Choi YO; Roh CK; Son SY; Hur H; Han SU
    Ann Surg Oncol; 2021 Nov; 28(12):7038-7039. PubMed ID: 33682019
    [No Abstract]   [Full Text] [Related]  

  • 10. ASO Author Reflections: Association Between Perioperative Blood Transfusion, Infections, and Prognosis of Stage II/III Gastric Cancer Patients.
    Xiao H; Luo J
    Ann Surg Oncol; 2021 Apr; 28(4):2405-2406. PubMed ID: 32901310
    [No Abstract]   [Full Text] [Related]  

  • 11. ASO Author Reflections: Quality of Life After Gastrectomy for Cancer.
    Hu Y; Strong VE
    Ann Surg Oncol; 2021 Jan; 28(1):57-58. PubMed ID: 33169300
    [No Abstract]   [Full Text] [Related]  

  • 12. Borrmann type IV gastric cancer should be classified as pT4b disease.
    Huang JY; Wang ZN; Lu CY; Miao ZF; Zhu Z; Song YX; Xu HM; Xu YY
    J Surg Res; 2016 Jun; 203(2):258-67. PubMed ID: 27363630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ASO Author Reflections: Comparison of Sarcopenia and Cachexia for Their Prognostic Value in Gastric Cancer Patients at Different TNM Stages After Gastrectomy.
    Zhuang CL; Dong QT; Chen XL; Wang SL
    Ann Surg Oncol; 2022 Dec; 29(Suppl 3):585-586. PubMed ID: 35000077
    [No Abstract]   [Full Text] [Related]  

  • 14. ASO Author Reflections: How Can We Accurately Predict Patients Expected to Be Malnourished After Gastrectomy?
    Park JH; Kim E; Lee HJ
    Ann Surg Oncol; 2021 Aug; 28(8):4482-4483. PubMed ID: 33486647
    [No Abstract]   [Full Text] [Related]  

  • 15. ASO Author Reflection: Tending Towards a Personalized Treatment for Advanced Gastric Cancer Patients by Adding the Conversion Surgery.
    Chen GM; Nie RC; Chen YB
    Ann Surg Oncol; 2020 Oct; 27(11):4261-4262. PubMed ID: 32405977
    [No Abstract]   [Full Text] [Related]  

  • 16. ASO Author Reflections: Using the Gastric Cancer Peritoneal Carcinomatosis Risk Score to Inform Surveillance and Treatment.
    Selleck M; Senthil M
    Ann Surg Oncol; 2020 Jan; 27(1):248-249. PubMed ID: 31659634
    [No Abstract]   [Full Text] [Related]  

  • 17. [Metastasis rates of lymph nodes and distribution in advanced gastric cancer and its clinical significance].
    Nzengue JC; Zhan WH; Wang JP; Dong WG; Lan P; He YL; Chen ZX; Cai SR
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Nov; 9(6):506-9. PubMed ID: 17143796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Rational surgical operations for advanced cancers located in the middle of the stomach].
    Furukawa H; Iwanaga T; Hiratsuka M; Imaoka S; Fukuda I; Kabuto T; Koyama H
    Nihon Geka Gakkai Zasshi; 1989 Sep; 90(9):1322-5. PubMed ID: 2586412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited significance of curative surgery in Borrmann type IV gastric cancer.
    Kim EY; Yoo HM; Song KY; Park CH
    Med Oncol; 2016 Jul; 33(7):69. PubMed ID: 27251378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of the oral side safety margin in the resection of a Borrmann 4 type gastric cancer].
    Yamauchi M; Idota C; Kondo K; Satta T; Yaguchi T; Akiyama S; Ito K; Watanabe T; Nakashima N; Takagi H
    Gan No Rinsho; 1990 May; 36(6):700-3. PubMed ID: 2348556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.